Transdermal Testosterone is currently recommended for women who are receiving optimal hormone replacement therapy or HRT, but continue to suffer from a low libido or sex drive. This remains current best advice by the British Menopa…lnkd.in/eQDyKnDg lnkd.in/edRVyHWG

Happy International Women's Day. #iwd2023 This year the theme is #EmbraceEquity. 💜 lnkd.in/ergDxwjF

Happy International Women's Day #iwd2023 This year the theme is #embraceequity 💜 lnkd.in/ebhmy8AJ

I have endorsed this approach since 2020 based on the results of the randomised aged trial conducted in London. AgeX NEWS Breast cancer US recommends women start screening at 40 BMJ 2023; 381 doi: doi.org/10.1136/bmj.p1… (Published 11 May 2023) Cite this as: BMJ 2023;381:p1077

Fantastic news for all women diagnosed with breast cancer - the past 30 years have shown dramatic improvements in 5 year breast cancer death rates by 3 fold. Annual risks of death are 3% over 5 years for more than two thirds of women. bmj.com/content/381/bm…

Medical jargon can be a minefield and patients often wonder what the terminology means in their imaging reports (mammogram, ultrasound & breast density (BI-RADS)). Here are some of the common findings in these reports. londonbreasthealth.com/understanding-…

Being a BRCA1 gene carrier may have low penetration in the absence of a family history. Risk by 60 may be <30% compared to often quoted 80% life time. eClinicalMedicine thelancet.com/journals/eclin…

This is the most staggering advancement I have seen in our speciality in recent memory - TME Breast Care Network | Aptitude Health Company BostonGeneCorp 🤯 #precisionmedicine

Monica Morrow @ORBS23 Neoadjuvant chemotherapy downstages the axilla

Breast Conservation Surgery and Mastectomy Have Similar rate of local recurrence . It's all in the biology and the level of residual disease post chemo. : Annals of Surgery journals.lww.com/annalsofsurger…

For Breast Cancer Awareness Month, information about breast cancer, including lesser-known symptoms. By me, for The Telegraph with thanks to Dr Sammut The ICR & Professor Zoe Winters telegraph.co.uk/health-fitness…

Stay 'breast aware' this #BreastCancerAwarenessMonth. Understand your breast changes—it's a life-saving habit! For your peace of mind and fast test results, book an appt with our One-Stop Breast Clinic 📞 020 8949 9020 🌐 bit.ly/NVH_BreastClin… #EarlyDetection #BreastHealth

SOUND trial, 2023. Prospective randomized trial- Omission of axillary surgery noninferior to SLN bx with early breast cancer node - by exam and US. Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer jamanetwork.com/journals/jamao…

Post Menopausal weight gain is a significant risk factor that increases risks of breast cancer by 20-60%, whereas weight loss after menopause is associated with a decreased risk of breast cancer. bmj.com/content/382/bm…

We are delighted to support the use of this new anti HER2 drug called Pyrotinib for women with metastatic Stage 4 breast cancer. Pyrotinib effectively blocks all HER2 receptors and doubles disease free survival from 12 to 24 months. Amazing work

youtube.com/live/-hQX2SGlc… via YouTube Professor Martha Hickey describes how menopause is not one thing for all women in terms of its definition or how it feels - therefore there cannot be one treatment for all. Keep one's views based on emerging knowledge and clinical evidence

I am humbled and thrilled to be awarded this certificate of excellence by @iwantgreatcare I couldn't do it without the excellent team I work with at each of the hospitals for providing the best possible care for our patients. #cofexcellence2024

A breast lump is the most common symptom of breast cancer. What defines a lump? What do you look for? How do you self examine? All perceived lumps, need to be clinically checked to rule out cancer. londonbreasthealth.com/breast-cancer/…

Clinicians are increasingly faced with menopause induced issues after breast cancer treatment. A new pilot study called VIBRA, is evaluating the clinical benefits of vaginal prasterone or DHEA in breast cancer survivors, which may be the future.

Clinicians need to integrate discussions on genitourinary symptoms in breast cancer survivors, and also clarify referral pathways that formerly link Oncologists and Menopause specialists